Outlook Therapeutics Inc (OTLK)

[thermo]

There will be a shareholder vote.

1. approve the shares to be issued in the transaction (since more than 20% are being issue).
2. give the board the ability to enact a reverse to stay on NASDAQ.

The price of the issued shares is the lower of (a) $0.35 and (b) the average price leading up to the shareholder vote. So, if investors focus on the reverse, maybe we can see weakness and "b" above will apply. But this deal brought in a lot of new institutions, and I think most of them don't have a full position. So, this may be one of those rare circumstances where a reverse doesn't hurt the stock.